Lactobacillus rhamnosus GG: An overview to explore the rationale of its use in cancer

Frontiers in Pharmacology

Volumn 8, Issue SEP, 2017, Pages

  Banna, Giuseppe L ^a   Torino, Francesco ^b   Marletta, Francesco ^a   Santagati, Maria ^c   Salemi, Rossella ^c   Cannarozzo, Elisa ^c   Falzone, Luca ^c   Ferraù, Francesco ^d   Libra, Massimo ^c  

^a CANNIZZARO HOSPITAL   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d Medical Oncology Unit San Vincenzo Hospital   (Italy)

Author keywords

Cancer; Chemotherapy; Diarrhea; Immunotherapy; Lactobacillus rhamnosus GG; Probiotics; Radiotherapy

Indexed keywords

PROBIOTIC AGENT;

ANTIINFLAMMATORY ACTIVITY; BACTEREMIA; BLADDER CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL INVASION; CELL PROLIFERATION; COLON CANCER; DIARRHEA; DISEASE SEVERITY; DRUG SAFETY; DYSBIOSIS; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS RHAMNOSUS GG; METABOLISM; METASTATIC COLORECTAL CANCER; NONHUMAN; QUALITY OF LIFE; REVIEW; STOMACH CARCINOMA; TUMOR INVASION;

EID: 85028944723     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00603     Document Type: Review

References (97)

1. Andreyev, H. J., Davidson, S. E., Gillespie, C., Allum, W. H., Swarbrick, E., British Society of Gastroenterology, et al. (2012). Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut 61, 179-192. doi: 10.1136/gutjnl-2011-300563
2. Arriola, E., Wheater, M., Lopez, M. A., Thomas, G., and Ottensmeiera, C. (2016). Evaluation of immune infiltration in the colonic mucosa of patients with ipilimumab-related colitis. Oncoimmunology 5:1209615. doi: 10.1080/ 2162402X.2016.1209615
3. Ashraf, R., and Shah, N. P. (2014). Immune system stimulation by probiotic microorganisms. Crit. Rev. Food Sci. Nutr. 54, 938-956. doi: 10.1080/10408398. 2011.619671
4. Banna, G. L., Collovà, E., Gebbia, V., Lipari, H., Giuffrida, P., Cavallaro, S., et al. (2010). Anticancer oral therapy: emerging related issues. Cancer Treat. Rev. 36, 595-605. doi: 10.1016/j.ctrv.2010.04.005
5. Benson, A. B., Ajani, J. A., Catalano, R. B., Engelking, C., Kornblau, S. M., Martenson, J. A. Jr., et al. (2004). Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J. Clin. Oncol. 22, 2918-2926. doi: 10.1200/JCO.2004.04.132
6. Berthrong, M., and Fajardo, L. F. (1981). Radiation injury in surgical pathology. Part II. Alimentary tract. Am. J. Surg. Pathol. 5, 153-178. doi: 10.1097/ 00000478-198103000-00006
7. Cai, S., Kandasamy, M., Rahmat, J. N., Tham, S. M., Bay, B. H., Lee, Y. K., et al. (2016). Lactobacillus rhamnosus GG activation of dendritic cells and neutrophils depends on the dose and time of exposure. J. Immunol. Res. 2016:7402760. doi: 10.1155/2016/7402760
8. Candela, M., Guidotti, M., Fabbri, A., Brigidi, P., Franceschi, C., and Fiorentini, C. (2011). Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer. Crit. Rev. Microbiol. 37, 1-14. doi: 10.3109/1040841X. 2010.501760
9. Chaput, N., Lepage, P., Coutzac, C., Soularue, E., Le Roux, K., Monot, C., et al. (2017). Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Ann. Oncol. 28, 1368-1379. doi: 10.1093/annonc/mdx108
10. Ciorba, M. A., Riehl, T. E., Rao, M. S., Moon, C., Ee, X., Nava, G. M., et al. (2012). Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. Gut 61, 829-838. doi: 10.1136/gutjnl-2011-300367
11. Claes, I. J., Schoofs, G., Regulski, K., Courtin, P., Chapot-Chartier, M. P., Rolain, T., et al. (2012). Genetic and biochemical characterization of the cell wall hydrolase activity of the major secreted protein of Lactobacillus rhamnosus GG. PLoS ONE 7:e31588. doi: 10.1371/journal.pone.0031588
12. Conway, P. L., Gorbach, S. L., and Goldin, B. R. (1987). Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J. Dairy Sci. 70, 1-12. doi: 10.3168/jds.S0022-0302(87)79974-3
13. Coudeyras, S., Marchandin, H., Fajon, C., and Forestier, C. (2008). Taxonomic and strain-specific identification of the probiotic strain Lactobacillus rhamnosus 35 within the Lactobacillus casei group. Appl. Environ. Microbiol. 74, 2679-2689. doi: 10.1128/AEM.02286-07
14. Cramer, P., and Bresalier, R. S. (2017). Gastrointestinal and hepatic complications of immune checkpoint inhibitors. Curr. Gastroenterol. Rep. 19, 3. doi: 10.1007/ s11894-017-0540-6
15. Davis, C. D., and Milner, J. A. (2009). Gastrointestinal microflora, food components and colon cancer prevention. J. Nutr. Biochem. 20, 743-752. doi: 10.1016/j.jnutbio.2009.06.001
16. DeGruttola, A. K., Low, D., Mizoguchi, A., and Mizoguchi, E. (2016). Current understanding of dysbiosis in disease in human and animal models. Inflamm. Bowel Dis. 22, 1137-1150. doi: 10.1097/MIB.000000000 0000750
17. Delcenserie, V., Martel, D., Lamoureux, M., Amiot, J., Boutin, Y., and Roy, D. (2008). Immunomodulatory effects of probiotics in the intestinal tract. Curr. Issues Mol. Biol. 10, 37-54.
18. Delia, P., Sansotta, G., Donato, V., Frosina, P., Messina, G., De Renzis, C., et al. (2007). Use of probiotics for prevention of radiation-induced diarrhea. World J. Gastroenterol. 13, 912-915. doi: 10.3748/wjg.v13.i6.912
19. Demers, M., Dagnault, A., and Desjardins, J. (2014). A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation. Clin. Nutr. 33, 761-767. doi: 10.1016/j.clnu.2013.10.015
20. Denham, J. W., and Hauer-Jensen, M. (2002). The radiotherapeutic injury - a complex 'wound'. Radiother. Oncol. 63, 129-145. doi: 10.1016/S0167-8140(02) 00060-9
21. Derosa, L., Routy, B., Enot, D., Baciarello, G., Massard, C., Loriot, Y., et al. (2017). Impact of antibiotics on outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Paper Presented at the Genitourinary Cancers Symposium, Orlando, FL. doi: 10.1200/JCO.2017.35.6_ suppl.462
22. Elmadfa, I., Klein, P., and Meyer, A. L. (2010). Immune-stimulating effects of lactic acid bacteria in vivo and in vitro. Proc. Nutr. Soc. 69, 416-420. doi: 10.1017/S0029665110001710
23. Escamilla, J., Lane, M. A., and Maitin, V. (2012). Cell-free supernatants from probiotic Lactobacillus casei and Lactobacillus rhamnosus GG decrease colon cancer cell invasion in vitro. Nutr. Cancer 64, 871-878. doi: 10.1080/01635581. 2012.700758
24. FAO/WHO (2002). Joint Working Group. Guidelines for the Evaluation of Probiotics in Food. Geneva: WHO.
25. Fuccio, L., Guido, A., Eusebi, L. H., Laterza, L., Grilli, D., Cennamo, V., et al. (2009). Effects of probiotics for the prevention and treatment of radiationinduced diarrhea. J. Clin. Gastroenterol. 43, 506-513. doi: 10.1097/MCG. 0b013e3181a1f59c
26. Gamallat, Y., Meyiah, A., Kuugbee, E. D.,Hago, A. M., Chiwala, G., Awadasseid, A., et al. (2016). Lactobacillus rhamnosus induced epithelial cell apoptosis, ameliorates inflammation and prevents colon cancer development in an animal model. Biomed. Pharmacother. 83, 536-541. doi: 10.1016/j.biopha.2016.07.001
27. Gibson, R. J., and Stringer, A. M. (2009). Chemotherapy-induced diarrhoea. Curr. Opin. Support. Palliat. Care 3, 31-35. doi: 10.1097/SPC.0b013e32832531bb
28. Gill, H. S., Rutherfurd, K. J., Prasad, J., and Gopal, P. K. (2000). Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br. J. Nutr. 83, 167-176. doi: 10.1017/S0007114500000210
29. Goldin, B. R., Gorbach, S. L., Saxelin, M., Barakat, S., Gualtieri, L., and Salminen, S. (1992). Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 37, 121-128. doi: 10.1007/BF01308354
30. Goldin, B. R., Gualtieri, L. J., and Moore, R. P. (1996). The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat. Nutr. Cancer 25, 197-204. doi: 10.1080/01635589609514442
31. Gorbach, S. L. (1996). The discovery of Lactobacillus GG. Nutr. Today 31, 2S-5S. doi: 10.1097/00017285-199611001-00002
32. Guandalini, S. (2011). Probiotics for prevention and treatment of diarrhea. J. Clin. Gastroenterol. 45(Suppl.), S149-S153. doi: 10.1097/MCG.0b013e3182257e98
33. Hatoum, O. A., Otterson, M. F., Kopelman, D., Miura, H., Sukhotnik, I., Larsen, B. T., et al. (2006). Radiation induces endothelial dysfunction in murine intestinal arterioles via enhanced production of reactive oxygen species. Arterioscler. Thromb. Vasc. Biol. 26, 287-294. doi: 10.1161/01.ATV.0000198399. 40584.8c
34. Hibberd, P. L., Kleimola, L., Fiorino, A. M., Botelho, C., Haverkamp, M., Andreyeva, I., et al. (2014). No evidence of harms of probiotic Lactobacillus rhamnosus GG ATCC 53103 in healthy elderly-a phase i open label study to assess safety, tolerability and cytokine responses. PLoS ONE 9:e113456. doi: 10.1371/journal.pone.0113456
35. Hirsh, V., Blais, N., Burkes, R., Verma, S., and Croitoru, K. (2014). Management of diarrhea induced by epidermal growth factor receptor tyrosine kinase inhibitors. Curr. Oncol. 21, 329-336. doi: 10.3747/co.21.2241
36. Hullar, A. J. M., and Fu, B. C. (2014). Diet, the gut microbiome, and epigenetics. Cancer J. 20, 170-175. doi: 10.1097/PPO.0000000000000053
37. Kankainen, M., Paulin, L., Tynkkynen, S., von Ossowski, I., Reunanen, J., Partanen, P., et al. (2009). Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human- mucus binding protein. Proc. Natl. Acad. Sci. U.S.A. 106, 17193-17198. doi: 10.1073/pnas.090 8876106
38. Keefe, D., and Anthony, L. (2008). Tyrosine kinase inhibitors and gut toxicity: a new era in supportive care. Curr. Opin. Support. Palliat. Care 2, 19-21. doi: 10.1097/SPC.0b013e3282f5273f
39. Keefe, D. M. K., Brealey, J., Goland, G. J., and Cummins, A. G. (2000). Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47, 632-637. doi: 10.1136/gut.47.5.632
40. Khailova, L., Baird, C. H., Rush, A. A., Barnes, C., and Wischmeyer, P. E. (2016). Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates inflammatory response and homeostasis of spleen and colon in experimental model of Pseudomonas aeruginosa pneumonia. Clin. Nutr. doi: 10.1016/j.clnu.2016.09.025 [Epub ahead of print].
41. Kleizen, B., Braakman, I., and de Jonge, H. R. (2000). Regulated trafficking of the CFTR chloride channel. Eur. J. Cell Biol. 79, 544-556. doi: 10.1078/0171-9335- 00078
42. Korhonen, R., Kosonen, O., Korpela, R., and Moilanen, E. (2004). The expression of COX2 protein induced by Lactobacillus rhamnosus GG, endotoxin and lipoteichoic acid in T84 epithelial cells. Lett. Appl. Microbiol. 39, 19-24. doi: 10.1111/j.1472-765X.2004.01531.x
43. Koskenniemi, K., Koponen, J., Kankainen, M., Savijoki, K., Tynkkynen, S., de Vos, W. M., et al. (2009). Proteome analysis of Lactobacillus rhamnosus GG using 2-D DIGE and mass spectrometry shows differential protein production in laboratory and industrial-type growth media. J. Proteome Res. 8, 4993-5007. doi: 10.1021/pr9003823
44. Krautkramer, K. A., Kreznar, J. H., Romano, K. A., Vivas, E. I., Barrett-Wilt, G. A., Rabaglia, M. E., et al. (2016). Diet-microbiota interactions mediate global epigenetic programming in multiple host tissues. Mol. Cell 64, 982-992. doi: 10.1016/j.molcel.2016.10.025
45. Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., and Shetty, A. K. (2005). Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115, 178-181. doi: 10.1542/peds.2004-2137
46. Larqué, E., Sabater-Molina, M., and Zamora, S. (2007). Biological significance of dietary polyamines. Nutrition 23, 87-95. doi: 10.1016/j.nut.2006.09.006
47. Lebeer, S., Verhoeven, T. L., Francius, G., Schoofs, G., Lambrichts, I., Dufrêne, Y., et al. (2009). Identification of a gene cluster for the biosynthesis of a long, galactose-rich exopolysaccharide in Lactobacillus rhamnosus GG and functional analysis of the priming glycosyltransferase. Appl. Environ. Microbiol. 75, 3554-3563. doi: 10.1128/AEM.02919-08
48. Lee, C. S., Ryan, E. J., and Doherty, G. A. (2014). Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation. World J. Gastroenterol. 20, 3751-3761. doi: 10.3748/wjg.v20.i14.3751
49. Ley, R. E., Peterson, D. A., and Gordon, J. I. (2006). Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124, 837-848. doi: 10.1016/j.cell.2006.02.017
50. Lin, L., and Zhang, J. (2017). Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol. 18:2. doi: 10.1186/s12865- 016-0187-3
51. Linsalata, M., Cavallini, A., Messa, C., Orlando, A., Refolo, M. G., and Russo, F. (2010). Lactobacillus rhamnosus GG influences polyamine metabolism in HGC-27 gastric cancer cell line: a strategy toward nutritional approach to chemoprevention of gastric cancer. Curr. Pharm. Des. 16, 847-853. doi: 10.2174/138161210790883598
52. Lopez, M., Li, N., Kataria, J., Russell, M., and Neu, J. (2008). Live and ultravioletinactivated Lactobacillus rhamnosus GG decrease flagellin-induced interleukin- 8 production in Caco-2 cells. J. Nutr. 138, 2264-2268. doi: 10.3945/jn.108. 093658
53. Lundelin, K., Poussa, T., Salminen, S., and Isolauri, E. (2017). Long-term safety and efficacy of perinatal probiotic intervention: evidence from a follow-up study of four randomized, double-blind, placebo-controlled trials. Pediatr. Allergy Immunol. 28, 170-175. doi: 10.1111/pai.12675
54. Majcher-Peszynska, J., Heine, W., Richter, I., Eggers, G., and Mohr, C. (1999). Persistent Lactobacillus casei subspecies rhamnosus bacteremia in a 14 year old girl with acute myeloid leukemia. A case report. Klin. Padiatr. 211, 53-56. doi: 10.1055/s-2008-1043764
55. Mantis, N. J., Rol, N., and Corthésy, B. (2011). Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 4, 603-611. doi: 10.1038/mi.2011.41
56. Mantovani, A. (2010). Molecular pathways linking inflammation and cancer. Curr. Mol. Med. 10, 369-373. doi: 10.2174/156652410791316968
57. Marco, M. L., Pavan, S., and Kleerebezem, M. (2006). Towards understanding molecular modes of probiotic action. Curr. Opin. Biotechnol. 17, 204-210. doi: 10.1016/j.copbio.2006.02.005
58. McQuade, R. M., Stojanovska, V., Abalo, R., Bornstein, J. C., and Nurgali, K. (2016). Chemotherapy-induced constipation and diarrhea: pathophysiology, current and emerging treatments. Front. Pharmacol. 7:414. doi: 10.3389/fphar.2016. 00414
59. Mego, M., Chovanec, J., Vochyanova-Andrezalova, I., Konkolovsky, P., Mikulova, M., Reckova, M., et al. (2015). Prevention of irinotecan induced diarrhea by probiotics: a randomized double blind, placebo controlled pilot study. Complement. Ther. Med. 23, 356-362. doi: 10.1016/j.ctim.2015.03.008
60. Morita, H., Toh, H., Oshima, K., Murakami, M., Taylor, T. D., Igimi, S., et al. (2009). Complete genome sequence of the probiotic Lactobacillus rhamnosus ATCC 53103. J. Bacteriol. 191, 7630-7631. doi: 10.1128/JB.01287-09
61. Orlando, A., Linsalata, M., and Russo, F. (2016). Antiproliferative effects on colon adenocarcinoma cells induced by co-administration of vitamin K1 and Lactobacillus rhamnosus GG. Int. J. Oncol. 48, 2629-2638. doi: 10.3892/ijo.2016. 3463
62. Osterlund, P., Ruotsalainen, T., Korpela, R., Saxelin, M., Ollus, A., Valta, P., et al. (2007). Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br. J. Cancer 97, 1028-1034. doi: 10.1038/sj.bjc.6603990
63. Ouwehand, A. C., Saxelin, M., and Salminen, S. (2004). Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood. Clin. Infect. Dis. 39, 1858-1860. doi: 10.1086/425741
64. Pace, F., Pace, M., and Quartarone, G. (2015). Probiotics in digestive diseases: focus on Lactobacillus GG. Minerva Gastroenterol. Dietol. 61, 273-292.
65. Parnes, H. L., Fung, E., and Schiffer, C. A. (1994). Chemotherapy-induced lactose intolerance in adults. Cancer 74, 1629-1633. doi: 10.1002/1097-0142(19940901) 74:5<1629::AID-CNCR2820740523>3.0.CO;2-L
66. Redman, M. G., Ward, E. J., and Phillips, R. S. (2014). The efficacy and safety of probiotics in people with cancer: a systematic review. Ann. Oncol. 25, 1919-1929. doi: 10.1093/annonc/mdu106
67. Riehl, T., Cohn, S., Tessner, T., Schloemann, S., and Stenson, W. F. (2000). Lipopolysaccharide is radioprotective in the mouse intestine through a prostaglandin-mediated mechanism. Gastroenterology 118, 1106-1116. doi: 10.1016/S0016-5085(00)70363-5
68. Robin, F., Paillard, C., Marchandin, H., Demeocq, F., Bonnet, R., and Hennequin, C. (2010). Lactobacillus rhamnosus meningitis following recurrent episodes of bacteremia in a child undergoing allogeneic hematopoietic stem cell transplantation. J. Clin. Microbiol. 48, 4317-4319. doi: 10.1128/JCM.00250-10
69. Rokka, S., Myllykangas, S., and Joutsjoki, V. (2008). Effect of specific colostral antibodies and selected lactobacilli on the adhesion of Helicobacter pylori on AGS cells and the Helicobacter-induced IL-8 production. Scand. J. Immunol. 68, 280-286. doi: 10.1111/j.1365-3083.2008.02138.x
70. Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., et al. (2004). Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin. Infect. Dis. 38, 62-69. doi: 10.1086/380455
71. Salminen, M. K., Rautelin, H., Tynkkynen, S., Poussa, T., Saxelin, M., Valtonen, V., et al. (2006). Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin. Infect. Dis. 42, e35-e44. doi: 10.1086/ 500214
72. Salminen, M. K., Tynkkynen, S., Rautelin, H., Saxelin, M., Vaara, M., Ruutu, P., et al. (2002). Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin. Infect. Dis. 35, 1155-1160. doi: 10.1086/342912
73. Scalabrin, D., Harris, C., Johnston, W. H., and Berseth, C. L. (2017). Long-term safety assessment in children who received hydrolyzed protein formulas with Lactobacillus rhamnosus GG: a 5-year follow-up. Eur. J. Pediatr. 176, 217-224. doi: 10.1007/s00431-016-2825-4
74. Scalabrin, D. M., Johnston, W. H., Hoffman, D. R., P'Pool, V. L., Harris, C. L., and Mitmesser, S. H. (2009). Growth and tolerance of healthy term infants receiving hydrolyzed infant formulas supplemented with Lactobacillus rhamnosus GG: randomized, double-blind, controlled trial. Clin. Pediatr. (Phila). 48, 734-744. doi: 10.1177/0009922809332682
75. Sekirov, I., Russell, S. L., Antunes, L. C. M., and Finlay, B. B. (2010). Gut microbiota in health and disease. Physiol. Rev. 90, 859-904. doi: 10.1152/physrev.00045. 2009
76. Seow, S. W., Cai, S., Rahmat, J. N., Bay, B. H., Lee, Y. K., Chan, Y. H., et al. (2010). Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors. Cancer Sci. 101, 751-758. doi: 10.1111/j.1349-7006. 2009.01426.x
77. Shanahan, F. (2012). A commentary on the safety of probiotics. Gastroenterol. Clin. North Am. 41, 869-876. doi: 10.1016/j.gtc.2012.08.006
78. Sheih, Y. H., Chiang, B. L., Wang, L. H., Liao, C. K., and Gill, H. S. (2001). Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus HN001. J. Am. Coll. Nutr. 20, 149-156. doi: 10.1080/07315724.2001.10719027
79. Siegel, R. L., Miller, K. D., and Jemal, A. (2017). Cancer statistics, 2017. CA Cancer J. Clin. 67, 7-30. doi: 10.3322/caac.21387
80. Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., et al. (2015). Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084-1089. doi: 10.1126/ science.aac4255
81. Spiller, R. (2008). Review article: probiotics and prebiotics in irritable bowel syndrome. Aliment. Pharmacol. Ther. 28, 385-396. doi: 10.1111/j.1365-2036. 2008.03750
82. Stansborough, R. L., Bateman, E. H., Al-Dasooqi, N., Bowen, J. M., Keefe, D. M. K., Yeoh, A. S. J., et al. (2017). Fractionated abdominal irradiation induces intestinal microvascular changes in an in vivo model of radiotherapy-induced gut toxicity. Support. Care Cancer 25, 1973-1983. doi: 10.1007/s00520-017- 3601-3
83. Stein, A., Voigt, W., and Jordan, K. (2010). Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther. Adv. Med. Oncol. 2, 51-63. doi: 10.1177/1758834009355164
84. Stenson, W. F. (2008). Toll-like receptors and intestinal epithelial repair. Curr. Opin. Gastroenterol. 24, 103-107. doi: 10.1097/MOG.0b013e3282f 44a2a
85. Stringer, A. M., Gibson, R. J., Logan, R. M., Bowen, J. M., Yeoh, A. S., Burns, J., et al. (2007). Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat. Exp. Biol. Med. 232, 96-106.
86. The Human Microbiome Project Consortium (2012). Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214. doi: 10.1038/ nature11234
87. Tjalsma, H., Boleij, A., Marchesi, J. R., and Dutilh, B. E. (2012). A bacterial driverpassenger model for colorectal cancer: beyond the usual suspects. Nat. Rev. Microbiol. 10, 575-582. doi: 10.1038/nrmicro2819
88. Uribe, J. M., Gelbmann, C. M., Traynor-Kaplan, A. E., and Barrett, K. E. (1996). Epidermal growth factor inhibits Ca (2C)-dependent Cl- transport in T84 human colonic epithelial cells. Am. J. Physiol. Cell Physiol. 271, C914-C922.
89. Van Sebille, Y. Z., Stansborough, R., Wardill, H. R., Bateman, E., Gibson, R. J., and Keefe, D. M. (2015). Management of mucositis during chemotherapy: from pathophysiology to pragmatic therapeutics. Curr. Oncol. Rep. 17, 50. doi: 10.1007/s11912-015-0474-9
90. Vetizou, M., Pitt, J. M., Daillere, R., Lepage, P., Waldschmitt, N., Flament, C., et al. (2015). Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079-1084. doi: 10.1126/science.aad1329
91. Villion, M., and Moineau, S. (2009). Bacteriophages of lactobacillus. Front. Biosci. (Landmark Ed). 14:1661-1683. doi: 10.2741/3332
92. Wang, Y., Liu, L., Moore, D. J., Shen, X., Peek, R. M., Acra, S. A., et al. (2017). An LGG-derived protein promotes IgA production through upregulation of APRIL expression in intestinal epithelial cells. Mucosal Immunol. 10, 373-384. doi: 10.1038/mi.2016.57
93. Wang, Y. H., Yao, N., Wei, K. K., Jiang, L., Hanif, S., Wang, Z. X., et al. (2016). The efficacy and safety of probiotics for prevention of chemoradiotherapy-induced diarrhea in people with abdominal and pelvic cancer: a systematic review and meta-analysis. Eur. J. Clin. Nutr. 70, 1246-1253. doi: 10.1038/ejcn.2016.102
94. Waugh, D. J., and Wilson, C. (2008). The interleukin-8 pathway in cancer. Clin. Cancer Res. 14, 6735-6741. doi: 10.1158/1078-0432.CCR-07-4843
95. Wedlake, L., Thomas, K., McGough, C., and Andreyev, H. J. (2008). Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: an observational study. Eur. J. Cancer 44, 2212-2217. doi: 10.1016/j.ejca.2008. 07.018
96. Zein, E. F., Karaa, S., Chemaly, A., Saidi, I., Daou-Chahine, W., and Rohban, R. (2008). Lactobacillus rhamnosus septicemia in a diabetic patient associated with probiotic use: a case report. Ann. Biol. Clin. (Paris) 66, 195-198. doi: 10.1684/ abc.2008.0210
97. Zoetendal, E. G., Rajilíc-Stojanovíc, M., and de Vos, W. M. (2008). Highthroughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57, 1605-1615. doi: 10.1136/gut.2007.133603